Status:
COMPLETED
Risk Assessment and Treat Compliance in Hypertension Education Trial
Lead Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Collaborating Sponsors:
University of Western Ontario, Canada
The Physicians' Services Incorporated Foundation
Conditions:
Hypertension
Dyslipidemia
Eligibility:
All Genders
30-84 years
Phase:
NA
Brief Summary
The RATCHET study assesses if patient knowledge of estimated cardiovascular risk at current and recommended target blood pressure levels improves compliance in the management of hypertension.
Eligibility Criteria
Inclusion
- Essential hypertension (new diagnosis or established diagnosis) meeting criteria for pharmacologic therapy as defined by current guidelines
Exclusion
- Lack of written informed consent
- Previous myocardial infarction
- Previous stroke
- Congestive heart failure
- Stage 3 or greater chronic kidney disease
- Pregnancy
- Usage of medication bubble/blister package
Key Trial Info
Start Date :
May 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2011
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00694239
Start Date
May 1 2007
End Date
March 1 2011
Last Update
June 30 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Western Ontario
London, Ontario, Canada, N6A 5A5